Enterococcus faecalis Gelatinase(gelE) antibody and antigen (recombinant protein)

Diagnostic anti-Enterococcus faecalis Gelatinase(gelE) antibodies pairs and antigen for animal health (animal Cat/Feline, Dog/Canine, Rabbit, Bovines/Cattle, Equine/Horse, Ovines/Sheep, Caprine/Goat, Fish, Swine/Porcine/Pig, Avian/Bird/Poultry infectious disease endocarditis, urinary tract infections, prostatitis, intra-abdominal infection, cellulitis, and wound infection) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Multiple species disease testing products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-VT-P272-Tg001-Ag01 Recombinant Enterococcus faecalis Gelatinase(gelE) protein $3090.00
GMP-VT-P272-Tg001-Ab01 Anti-Enterococcus faecalis Gelatinase(gelE) mouse monoclonal antibody (mAb) $3090.00
GMP-VT-P272-Tg001-Ab02 Anti-Enterococcus faecalis Gelatinase(gelE) mouse monoclonal antibody (mAb) $3090.00
GMP-VT-P272-Tg001-Ab03 Anti-Enterococcus faecalis Gelatinase(gelE) human monoclonal antibody (mAb) $3090.00
GMP-VT-P272-Tg001-Ab04 Anti-Enterococcus faecalis Gelatinase(gelE) human monoclonal antibody (mAb) $3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-VT-P272-Tg001-Ag01
Product Name Recombinant Enterococcus faecalis Gelatinase(gelE) protein
Pathogen Enterococcus faecalis
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Enterococcus faecalis Gelatinase(gelE) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Enterococcus faecalis level test of animal Cat/Feline, Dog/Canine, Rabbit, Bovines/Cattle, Equine/Horse, Ovines/Sheep, Caprine/Goat, Fish, Swine/Porcine/Pig, Avian/Bird/Poultry infectious disease with endocarditis, urinary tract infections, prostatitis, intra-abdominal infection, cellulitis, and wound infection.
Tag His
Product description Recombinant Enterococcus faecalis Gelatinase(gelE) proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. GMP-VT-P272-Tg001-Ab01,GMP-VT-P272-Tg001-Ab02
Pathogen Enterococcus faecalis
Product Name Anti-Enterococcus faecalis Gelatinase(gelE) mouse monoclonal antibody (mAb)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Enterococcus faecalis Gelatinase(gelE) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Enterococcus faecalis antibodies in Enterococcus faecalis level test of animal Cat/Feline, Dog/Canine, Rabbit, Bovines/Cattle, Equine/Horse, Ovines/Sheep, Caprine/Goat, Fish, Swine/Porcine/Pig, Avian/Bird/Poultry infectious disease with endocarditis, urinary tract infections, prostatitis, intra-abdominal infection, cellulitis, and wound infection.
Product description Anti-Enterococcus faecalis Gelatinase(gelE) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Enterococcus faecalis antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. GMP-VT-P272-Tg001-Ab03,GMP-VT-P272-Tg001-Ab04
Pathogen Enterococcus faecalis
Product Name Anti-Enterococcus faecalis Gelatinase(gelE) human monoclonal antibody (mAb)
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation Recombinant Enterococcus faecalis Gelatinase(gelE) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Enterococcus faecalis antibodies in Enterococcus faecalis level test of animal Cat/Feline, Dog/Canine, Rabbit, Bovines/Cattle, Equine/Horse, Ovines/Sheep, Caprine/Goat, Fish, Swine/Porcine/Pig, Avian/Bird/Poultry infectious disease with endocarditis, urinary tract infections, prostatitis, intra-abdominal infection, cellulitis, and wound infection.
Product description Anti-Enterococcus faecalis Gelatinase(gelE) mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Pathogen Information


    Enterococcus faecalis is a Gram-positive bacterium that belongs to the genus Enterococcus, which is a part of the phylum Firmicutes. It was first described by Theodor Escherich in 1899 and is widely found in the environment, including soil, water, plants, and animals. In humans, it is a normal inhabitant of the gastrointestinal tract and can also be found in the oral cavity, urinary tract, and female genital tract. However, under certain conditions, such as antibiotic treatment or immunosuppression, this bacterium can cause infections and become pathogenic.

    Enterococcus faecalis has a spherical shape with a diameter of approximately 0.5-1.0 μm and is surrounded by a cell wall composed of peptidoglycan, teichoic acids, and lipoteichoic acids. Its genome consists of around 3 million base pairs and encodes for various virulence factors, including cytolysin, gelatinase, and aggregation substance. Cytolysin is a pore-forming toxin that damages host cells, while gelatinase facilitates tissue invasion and degradation. Aggregation substance promotes bacterial adherence and biofilm formation, enabling the bacterium to resist host immune defenses and antimicrobial agents.

    One of the most notable features of Enterococcus faecalis is its ability to acquire antibiotic resistance genes through horizontal gene transfer. This has made it a significant public health concern, as infections caused by resistant strains are difficult to treat and can have severe consequences. One of the most common resistance mechanisms involves the VanA gene, which is responsible for vancomycin resistance. The VanA protein confers resistance against glycopeptide antibiotics by altering the structure of the bacterial cell wall, rendering it impermeable to the drug. Other important resistance genes include those encoding for beta-lactamases, aminoglycoside-modifying enzymes, and efflux pumps.

    Enterococcus faecalis is known to cause a variety of infections in humans, including urinary tract infections, endocarditis, bacteremia, and wound infections. It can also infect animals such as dogs, cats, and pigs. It is often associated with hospital-acquired infections and is frequently found in medical devices, such as catheters. The pathogenesis of Enterococcus faecalis infections is complex and involves multiple factors, including bacterial adhesion, colonization, invasion, and systemic dissemination. The host immune response also plays a crucial role in determining the outcome of the infection.

    Diagnostic methods for Enterococcus faecalis infection involve the culture of samples taken from infected areas, such as blood, urine, or wounds. These samples can be plated on agar media, followed by microscopy and biochemical testing to identify the bacterium based on its specific characteristics. Nucleic acid amplification tests (NAATs), such as polymerase chain reaction (PCR) and real-time PCR, can also be used to detect specific genes associated with antibiotic resistance. These include the VanA gene and other genes encoding for factors such as cytolysin and biofilm formation. Additionally, matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry has been used for the rapid identification of Enterococcus species.

    Treatment of Enterococcus faecalis infections often involves the use of antibiotics, such as ampicillin, vancomycin, and linezolid. However, due to the high prevalence of antibiotic resistance, treatment options may be limited, and alternative therapies, such as bacteriophages and probiotics, are being explored. Vaccines targeting specific virulence factors, such as cytolysin and aggregation substance, have also been developed and may provide a promising approach to prevent infections caused by this bacterium.

    Overall, Enterococcus faecalis is a versatile bacterium that can inhabit many different environments and cause a range of infections in humans and animals. Its ability to acquire antibiotic resistance genes makes it a significant public health concern, and more research is needed to understand its pathogenesis and develop effective treatment and prevention strategies.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.